« Back to Record
Incorvaia, L., Fanale, D., Badalamenti, G., Porta, C., Olive, D., De Luca, I., Brando, C., Rizzo, M., Messina, C., Rediti, M., Russo, A., Bazan, V., & Iovanna, J.-L. (2020). Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions. Oncoimmunology, 9(1), 1832348. doi:10.1080/2162402X.2020.1832348
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/316725



